Closure of Trading Window
Filed with BSE · · 1 page · English
Sub: Closure of trading window Unit: Vista Pharmaceuticals Limited (Scrip Code: 524711) We would like to inform you that as per the Company's minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading)Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP/
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Board Meeting Intimation for Raising Of Funds By Way Of Issue Of Equity Or Convertible Warrants On Preferential Basis,
- Vista Pharmaceuticals Ltd. Press Release Feb 12 2025
- Integrated Filing (Financial)
- Results For The Quarter And Nine Months Ended 31.12.2024
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2025
Later from Vista Pharmaceuticals
- Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vista Pharmaceuticals Ltd. Press Release Feb 19 2025
- Notice Of Extra- Ordinary General Meeting Of The Company To Be Held On 20.03.2025
- Vista Pharmaceuticals Ltd. Press Release Feb 25 2025
- Shareholder Meeting / Postal Ballot-Outcome of EGM
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals